High‐throughput and multi‐phases identification of autoantibodies in diagnosing early‐stage breast cancer and subtypes

Autoantibodies (AAbs) targeted tumor‐associated antigens (TAAs) have the potential for early detection of breast cancer. Here, 574 early‐stage breast cancer (ES‐BC) patients containing 4 subtypes (Luminal A, Luminal B, HER2+, TN), 126 benign breast disease (BBD) patients, and 199 normal healthy cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Rongrong, Zheng, Cuiling, Song, Wenya, Tan, Qiaoyun, Shi, Yuankai, Han, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819333/
https://www.ncbi.nlm.nih.gov/pubmed/34843149
http://dx.doi.org/10.1111/cas.15227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819333/
https://www.ncbi.nlm.nih.gov/pubmed/34843149
http://dx.doi.org/10.1111/cas.15227

Ejemplares similares